Stay updated on Apremilast in Nummular Eczema Clinical Trial

Sign up to get notified when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apremilast in Nummular Eczema Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A banner announces that NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition. The clinical trial page continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-25T06:58:28.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2; the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-18T06:50:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T08:16:09.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with the site header and footer, indicating access is blocked rather than showing the study details.
    Difference
    19%
    Check dated 2026-09-20T04:23:15.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, representing a small update to the study record metadata rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T23:46:24.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, with no visible changes to the study details or page structure.
    Difference
    0.1%
    Check dated 2026-08-08T20:20:42.000Z thumbnail image

Stay in the know with updates to Apremilast in Nummular Eczema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apremilast in Nummular Eczema Clinical Trial page.